AS602801,
bentamapimod,
PGL5001,
Bentamapimod,
848344-36-5,
AS 602801,
AS-602801,
AS602801,
PGL-5001,
2-(1,3-benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile,
2-Benzothiazoleacetonitrile,a-[2-[[4-(4-morpholinylmethyl)phenyl]methoxy]-4-pyrimidinyl]-,
Bentamapimod [INN],
CS-0600,
AS602801(Bentamapimod),
cc-464,
MLS006010270,
AS 602801(Bentamapimod),
GTPL9926,
SCHEMBL2878382,
CHEMBL3545213,
AOB6044,
PGL5001,
BCP28061,
EX-A1361,
3453AH,
AKOS026750595,
RL05217,
SB17178,
VA12043,
(1,3-Benzothiazol-2-yl)[2-[[4-[(morpholin-4-yl)methyl]benzyl]oxy]pyrimidin-4-yl]acetonitrile,
NCGC00379069-03,
4CA-0186,
BC600638,
HY-14761,
SMR004701342,
J3.592.287C,
W-5369,
J-519665,
2-(Benzo[d]thiazol-2-yl)-2-(2-((4-(morpholinomethyl)benzyl)oxy)pyrimidin-4-yl)acetonitrile,
2-(benzo[d]thiazol-2-yl)-2-(2-(4-(morpholinomethyl)benzyloxy)pyrimidin-4-yl)acetonitrile,
AS-602801|||2-(1,3-Benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile,
bentamapimod; (1,3-benzothiazol-2-yl)(2-((4-((morpholin-4-yl)methyl)benzyl)oxy)pyrimidin-4-yl)acetonitrile,
UNII-TT3L4B4U0N,
D0W2KR,
TT3L4B4U0N,
C25H23N5O2S,
CS-0240,
CID10195250,
2-benzothiazol-2-yl-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile,
HDAC inhibitors (neurodegenerative diseases/viral infections/immune diseases), Shenzhen Chipscreen Biosciences,